Asco 2025 · Posters · Terapias en desarrollo · Oriol Mirallas, MD, MS Volver

Ultrasensitive ctDNA profiling to identify long-term survivors in phase I immunotherapy trials.

Abstract: 2560
Poster Bd #: 207
Descargar Poster

Oriol Mirallas, MD, MS

Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO)

Una iniciativa científica de: Eco Logo
Clover sgm Logo
Con el patrocinio de: Regeneron Logo